We are live on ! Find out more
CDMO

Avid Bioservices, Inc. Common Stock
CDMO

Delisted

CDMO was delisted on the 4th of February, 2025.

Back to rankings

174 hedge funds and large institutions have $381M invested in Avid Bioservices, Inc. Common Stock in 2023 Q4 according to their latest regulatory filings, with 44 funds opening new positions, 58 increasing their positions, 50 reducing their positions, and 39 closing their positions.

New
Increased
Maintained
Reduced
Closed

166% more call options, than puts

Call options by funds: $218K | Put options by funds: $82K

16% more repeat investments, than reductions

Existing positions increased: 58 | Existing positions reduced: 50

13% more first-time investments, than exits

New positions opened: 44 | Existing positions closed: 39

2% more funds holding

Funds holding: 170 → 174 (+4)

36% less capital invested

Capital invested by funds: $591M → $381M (-$210M)

Holders
174
Holders Change
+4
Holders Change %
+2.35%
% of All Funds
2.54%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
44
Increased
58
Reduced
50
Closed
39
Calls
$218K
Puts
$82K
Net Calls
+$136K
Net Calls Change
+$127K

Top Buyers

Rank Fund Capital Flow
1
Millennium Management
Millennium Management
New York
+$26.9M
2
Morgan Stanley
Morgan Stanley
New York
+$7.16M
3
State Street
State Street
Massachusetts
+$6.76M
4
Two Sigma Investments
Two Sigma Investments
New York
+$3.46M
5
2C
272 Capital
Texas
+$3.02M

Top Sellers

Rank Fund Capital Flow
1
BlackRock
BlackRock
New York
-$28.3M
2
GCM
Geneva Capital Management
Wisconsin
-$21.3M
3
Artisan Partners
Artisan Partners
Wisconsin
-$15.8M
4
RIM
Ranger Investment Management
Texas
-$14.7M
5
Jennison Associates
Jennison Associates
New York
-$14M
Name Holding Trade Value Shares
Change 		Change in
Stake
Two Sigma Advisers
51
Two Sigma Advisers
New York
$1.17M +$936K +145,190 +409%
N
52
Nuveen
North Carolina
$1.08M +$9.87K +1,531 +0.9%
CSS
53
Cubist Systematic Strategies
Connecticut
$1.05M +$1.04M +161,566 New
D.E. Shaw & Co
54
D.E. Shaw & Co
New York
$1.02M +$333K +51,680 +49%
Citigroup
55
Citigroup
New York
$997K +$302K +46,787 +44%
JF
56
Jump Financial
Illinois
$936K +$928K +144,049 New
SEI Investments
57
SEI Investments
Pennsylvania
$921K -$671K -104,060 -42%
AFM
58
Anson Funds Management
Texas
$886K +$879K +136,313 New
CI
59
Cooper Investors
Australia
$874K +$866K +134,400 New
TD Asset Management
60
TD Asset Management
Ontario, Canada
$830K +$82.5K +12,800 +11%
QOP
61
Quinn Opportunity Partners
Virginia
$824K +$701K +108,762 +603%
LPL Financial
62
LPL Financial
California
$820K -$145K -22,506 -15%
CS
63
Credit Suisse
Switzerland
$815K +$294K +45,643 +57%
Swiss National Bank
64
Swiss National Bank
Switzerland
$809K -$87K -13,500 -10%
M&T Bank
65
M&T Bank
New York
$673K +$114K +17,673 +21%
Jennison Associates
66
Jennison Associates
New York
$657K -$14M -2,169,738 -96%
State of Wisconsin Investment Board
67
State of Wisconsin Investment Board
Wisconsin
$655K +$313K +48,599 +93%
Deutsche Bank
68
Deutsche Bank
Germany
$641K +$418K +64,798 +191%
Walleye Capital
69
Walleye Capital
New York
$634K +$628K +97,487 New
Ameriprise
70
Ameriprise
Minnesota
$585K -$1.33M -206,973 -70%
JP Morgan Chase
71
JP Morgan Chase
New York
$573K +$67.9K +10,538 +14%
RhumbLine Advisers
72
RhumbLine Advisers
Massachusetts
$561K -$392K -60,889 -41%
CCM
73
Cinctive Capital Management
New York
$498K -$709K -109,976 -59%
Jane Street
74
Jane Street
New York
$489K +$243K +37,741 +101%
KA
75
Kerrisdale Advisers
Florida
$446K +$126K +19,526 +40%
1 2
3
4 5

CDMO Hedge Fund Activity: Q4 2023 in Review

174 of the 6,860 institutional investors tracked by Wall St. Rank reported a position in Avid Bioservices, Inc. Common Stock (CDMO) for Q4 2023, worth a combined $381M — down 36% from $591M a quarter earlier.

Buyers outnumbered sellers: 44 funds opened new CDMO positions and 39 closed out — a net gain of 5 holders — while 58 added to existing stakes and 50 trimmed.

The largest buyer was Millennium Management, adding an estimated $26.9M. The largest seller was BlackRock, cutting an estimated $28.3M.

  • 174 institutional investors held Avid Bioservices, Inc. Common Stock (CDMO) as of Q4 2023, up from 170 in Q3 2023.
  • Funds reported $381M of Avid Bioservices, Inc. Common Stock stock for Q4 2023, down 36% quarter-over-quarter.
  • 44 funds opened new Avid Bioservices, Inc. Common Stock positions in Q4 2023 and 39 closed out, a net change of +5 holders.
  • The largest Avid Bioservices, Inc. Common Stock buyer in Q4 2023 was Millennium Management, an estimated $26.9M added.
  • The largest Avid Bioservices, Inc. Common Stock seller in Q4 2023 was BlackRock, an estimated $28.3M sold.

Based on aggregated 13F filings for Q4 2023.